about
Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structureLipoprotein abnormalities in South Asians and its association with cardiovascular disease: Current state and future directionsMolecular mechanisms of cellular cholesterol effluxExpression of scavenger receptor class B type I in gallbladder columnar epitheliumJTT-705: is there still future for a CETP inhibitor after torcetrapib?Spatial distribution of the pathways of cholesterol homeostasis in human retinaIdentification and characterization of rodent ABCA1 in isolated type II pneumocytesDimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissuesChronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling.Atherothrombosis in South asians: implications of atherosclerotic and inflammatory markers.Extracellular hydrophobic regions in scavenger receptor BI play a key role in mediating HDL-cholesterol transport.Susceptibility gene for stroke or cerebral infarction in the Han population in Hunan Province of China.Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.Expression of scavenger receptor class B type 1 (SR-BI) promotes microvillar channel formation and selective cholesteryl ester transport in a heterologous reconstituted system.HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein.Protein mediators of sterol transport across intestinal brush border membrane.Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemiaReverse cholesterol transport and cholesterol efflux in atherosclerosis.Cholesterol efflux is differentially regulated in neurons and astrocytes: implications for brain cholesterol homeostasis.Excess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk?Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux.Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectivesSteroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide-treated mice.Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis.Nutrigenetics of the lipoprotein metabolism.LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos.Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.Alpinetin enhances cholesterol efflux and inhibits lipid accumulation in oxidized low-density lipoprotein-loaded human macrophages.Studies on scavenger receptors under experimental hypercholesterolemia: modulation on selenium supplementation.Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux.Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines.Differential regulation of steroid hormone biosynthesis in R2C and MA-10 Leydig tumor cells: role of SR-B1-mediated selective cholesteryl ester transport.The apolipoprotein E-dependent low density lipoprotein cholesteryl ester selective uptake pathway in murine adrenocortical cells involves chondroitin sulfate proteoglycans and an alpha 2-macroglobulin receptor.The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake.Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products.Apolipoprotein A-I is necessary for the in vivo formation of high density lipoprotein competent for scavenger receptor BI-mediated cholesteryl ester-selective uptake.Separation of lipid transport functions by mutations in the extracellular domain of scavenger receptor class B, type I.
P2860
Q24304399-BD60F771-C7EA-4637-AC88-3E2F609969EAQ26750131-43C3104E-65CA-4F88-BC70-49E2E7EC5C0AQ27021139-516505A7-25B6-44C0-B6BE-5DF06D83CAB9Q28213114-38D4B142-8442-464E-843B-7CBDEA8B856DQ28294797-82984039-2933-4AB6-ADBE-346BAC0A3AF1Q28483866-3E098888-C7E8-45CD-8F53-77C7216A3D9CQ28579200-334D6D05-32C0-4C1D-A560-DB444C2F8C56Q28582095-921C01A0-6CF8-4216-AE84-0EF00DA7610CQ30417042-D13862BF-6900-4841-A8B6-F09F4B5CAC51Q33736211-ACBA4874-5222-4EEC-8FA2-50AD145B1F7FQ33783351-7E9A8896-510C-41B8-8B00-38C8E4454A3DQ33937822-67BC0915-05B8-4034-A983-BC5F0F1EFE5BQ34048490-CA039F4F-5610-46F6-9F86-611164CE0CC3Q34093435-DB45C40F-0B78-4933-8105-A14C3D19745DQ34181607-E0B91477-F26B-480B-9949-7A5FE24F3AC2Q34188107-51CAF89A-D201-4C83-AC36-D866DE0D117EQ34786703-D5CC30AE-EAC3-415C-8631-50209D66821DQ35838266-75483797-1A80-4EA4-B228-35DCF9A9F08AQ35839693-F5CF3D8D-8D8C-405D-8182-33CDA0E4CE76Q36300834-11091381-F0E8-41C1-B3A5-6F700E67C21DQ36501289-BB34EEA8-F71F-4474-AB0E-EF7E3B776A64Q37019901-85BF966D-E3E8-48F8-BE88-05F73F98D413Q37086142-9CD27A57-3FF8-4FF0-A681-975DC72F8FE7Q37179102-2FD899D8-5D53-4E7F-A85B-8A80E1265A5BQ37262323-0649B6EB-E1C2-439C-BA9F-37972FFF1E12Q37297571-3FD713E9-2FAD-4607-BC59-B8E3AEE8410BQ37556265-B876C8CA-2542-463E-8BE1-B53BEDC79419Q37961647-1B098C13-40DB-4C43-B85F-9BAC8AF691E1Q38006731-CA489ACB-D4D7-4D60-9F4E-486A40FEFDE9Q38173896-3A50104F-5589-4BB0-9830-D222D3F55BE3Q38929978-8D0644F1-44DC-43B6-8073-93DFE1F630F5Q39836169-51DBFC42-5C62-411E-8BCF-2D41F39E9E5DQ40390167-2D3A386D-3E94-4BC0-A2AD-707EABA0A397Q40673438-76FD6A68-CF38-423B-97B6-3601652586CAQ40682227-5EB9DDD9-CB30-4895-9AA8-E39D939983C2Q40818007-0A4D2DEE-DFC8-4DE6-977A-809573B4C8BFQ40870561-7CBFFF67-F22B-46FD-9585-603523714772Q43560094-82F6BA5B-AB14-46DE-802A-0725B9FC8258Q43986679-91DE5C31-1A13-4758-9ACE-C5B180535B88Q44429253-B0590AB0-9586-406D-A171-A04D607549C8
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Scavenger receptor BI and cholesterol trafficking.
@ast
Scavenger receptor BI and cholesterol trafficking.
@en
type
label
Scavenger receptor BI and cholesterol trafficking.
@ast
Scavenger receptor BI and cholesterol trafficking.
@en
prefLabel
Scavenger receptor BI and cholesterol trafficking.
@ast
Scavenger receptor BI and cholesterol trafficking.
@en
P2093
P1476
Scavenger receptor BI and cholesterol trafficking.
@en
P2093
Connelly MA
Phillips MC
Rothblat GH
Swarnakar S
Williams DL
de la Llera-Moya M
P304
P356
10.1097/00041433-199908000-00007
P577
1999-08-01T00:00:00Z